Title:
NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME
Document Type and Number:
WIPO Patent Application WO/2022/181894
Kind Code:
A1
Abstract:
The present application relates to a novel bacteriophage having Clostridium perfringens-specific bactericidal effect and an antibacterial composition comprising same, the novel bacteriophage CJ_CP_20-25 having Clostridium perfringens-specific bactericidal effect, and being superbly acid and heat resistant to allow wide use in antibiotics, feed and additives therefor, beverages and additives therefor, disinfectants, detergents, and the like to prevent or treat infectious diseases caused by Clostridium perfringens.
More Like This:
Inventors:
JEON JONG SOO (KR)
KIM JI EUN (KR)
MOON JUN OK (KR)
CHAE JONG PYO (KR)
KIM YU JIN (KR)
LEE SEUNG EUN (KR)
KIM JI EUN (KR)
MOON JUN OK (KR)
CHAE JONG PYO (KR)
KIM YU JIN (KR)
LEE SEUNG EUN (KR)
Application Number:
PCT/KR2021/007484
Publication Date:
September 01, 2022
Filing Date:
June 15, 2021
Export Citation:
Assignee:
CJ CHEILJEDANG CORP (KR)
International Classes:
C12N7/00; A01N63/40; A23K10/16; A23K20/195; A61K35/76; A61P31/02; A61P31/04; C02F1/68; C11D3/38
Foreign References:
| KR20180074583A | 2018-07-03 | |||
| KR20160080175A | 2016-07-07 | |||
| KR101381797B1 | 2014-04-07 | |||
| US20090047726A1 | 2009-02-19 | |||
| US6942858B1 | 2005-09-13 |
Other References:
DATABASE Nucleotide Genbank; 16 September 2017 (2017-09-16), ANONYMOUS : "Clostridium phage CP3, partial genome - Nucleotide - NCBI", XP055961924, retrieved from NCBI Database accession no. MF001357
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: